Phreesia, Inc. (NYSE:PHR) General Counsel Allison C. Hoffman Sells 3,496 Shares

Phreesia, Inc. (NYSE:PHR - Get Free Report) General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $25.32, for a total transaction of $88,518.72. Following the transaction, the general counsel now directly owns 139,134 shares of the company's stock, valued at approximately $3,522,872.88. This trade represents a 2.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.

Phreesia Stock Performance

PHR stock traded down $0.16 on Friday, hitting $27.45. The company had a trading volume of 542,368 shares, compared to its average volume of 416,662. The stock has a market cap of $1.61 billion, a price-to-earnings ratio of -18.68 and a beta of 1.03. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.04. The stock's 50-day simple moving average is $27.33 and its 200 day simple moving average is $24.08. Phreesia, Inc. has a 12-month low of $17.07 and a 12-month high of $30.53.

Institutional Trading of Phreesia

Several large investors have recently modified their holdings of the company. Invesco Ltd. boosted its position in Phreesia by 0.9% in the fourth quarter. Invesco Ltd. now owns 40,249 shares of the company's stock worth $1,013,000 after purchasing an additional 357 shares during the last quarter. NewEdge Advisors LLC boosted its holdings in shares of Phreesia by 12.1% in the fourth quarter. NewEdge Advisors LLC now owns 4,256 shares of the company's stock worth $107,000 after buying an additional 459 shares during the last quarter. Johnson Financial Group Inc. grew its position in Phreesia by 381.3% during the fourth quarter. Johnson Financial Group Inc. now owns 1,131 shares of the company's stock valued at $28,000 after buying an additional 896 shares during the period. The Manufacturers Life Insurance Company grew its position in Phreesia by 3.3% during the third quarter. The Manufacturers Life Insurance Company now owns 27,935 shares of the company's stock valued at $637,000 after buying an additional 905 shares during the period. Finally, MetLife Investment Management LLC increased its holdings in Phreesia by 3.8% during the third quarter. MetLife Investment Management LLC now owns 30,781 shares of the company's stock valued at $701,000 after buying an additional 1,120 shares during the last quarter. Institutional investors own 92.10% of the company's stock.

Remove Ads

Analyst Ratings Changes

PHR has been the subject of a number of analyst reports. Royal Bank of Canada raised Phreesia from a "sector perform" rating to an "outperform" rating and raised their price objective for the company from $24.00 to $32.00 in a research report on Wednesday, January 8th. Citigroup raised their price target on Phreesia from $31.00 to $35.00 and gave the company a "buy" rating in a report on Friday, January 10th. Piper Sandler reiterated an "overweight" rating and issued a $33.00 price target (up previously from $31.00) on shares of Phreesia in a research note on Wednesday, January 29th. JMP Securities restated a "market outperform" rating and set a $30.00 price objective on shares of Phreesia in a research note on Tuesday, December 10th. Finally, Truist Financial upped their target price on shares of Phreesia from $31.00 to $34.00 and gave the stock a "buy" rating in a research note on Wednesday, December 11th. Twelve equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, Phreesia presently has a consensus rating of "Buy" and an average price target of $31.33.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.